negatives of glp 1 GLP-1 nausea: How to handle GLP-1s' most common side effect The Surprising Truth About Nutrition

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB

Glucagon Suppression: They suppress the release of glucagon, a hormone that raises blood sugar levels

Black/Gray Market Risks The emergence of counterfeit GLP-1 agonists on the black market has added another layer of risk

In a clinical trial, one-year dulaglutide treatment in individuals with chronic kidney disease (CKD) and T2D resulted in an increased estimated glomerular filtration rate compared to insulin glargine

The FLOW trial was the first clinical trial that evaluated the effects of a GLP-1 medicine, semaglutide, on a composite outcome of progression of CKD and cardiovascular death, in people with T2D

Winzeler, Bettina, Clara O